IndraLab

Statements



No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

reach
"Tofacitinib citrate which inhibits JAK1/JAK3 is approved for treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant o[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available